These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 21518864)

  • 1. Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans.
    Warner-Schmidt JL; Vanover KE; Chen EY; Marshall JJ; Greengard P
    Proc Natl Acad Sci U S A; 2011 May; 108(22):9262-7. PubMed ID: 21518864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluoxetine and citalopram exhibit potent antiinflammatory activity in human and murine models of rheumatoid arthritis and inhibit toll-like receptors.
    Sacre S; Medghalchi M; Gregory B; Brennan F; Williams R
    Arthritis Rheum; 2010 Mar; 62(3):683-93. PubMed ID: 20131240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin, cytokines, p11, and depression.
    Snyder SH
    Proc Natl Acad Sci U S A; 2011 May; 108(22):8923-4. PubMed ID: 21593414
    [No Abstract]   [Full Text] [Related]  

  • 4. Olanzapine augments the effect of selective serotonin reuptake inhibitors by suppressing GABAergic inhibition via antagonism of 5-HT₆ receptors in the dorsal raphe nucleus.
    Asaoka N; Nagayasu K; Nishitani N; Yamashiro M; Shirakawa H; Nakagawa T; Kaneko S
    Neuropharmacology; 2015 Aug; 95():261-8. PubMed ID: 25863120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurokinin1 antagonists potentiate antidepressant properties of serotonin reuptake inhibitors, yet blunt their anxiogenic actions: a neurochemical, electrophysiological, and behavioral characterization.
    Gobert A; Brocco M; Dekeyne A; Di Cara B; Bouchez G; Lejeune F; Gannon RL; Millan MJ
    Neuropsychopharmacology; 2009 Mar; 34(4):1039-56. PubMed ID: 18830239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AP-1 controls the p11-dependent antidepressant response.
    Chottekalapanda RU; Kalik S; Gresack J; Ayala A; Gao M; Wang W; Meller S; Aly A; Schaefer A; Greengard P
    Mol Psychiatry; 2020 Jul; 25(7):1364-1381. PubMed ID: 32439846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors.
    Cryan JF; O'Leary OF; Jin SH; Friedland JC; Ouyang M; Hirsch BR; Page ME; Dalvi A; Thomas SA; Lucki I
    Proc Natl Acad Sci U S A; 2004 May; 101(21):8186-91. PubMed ID: 15148402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressant treatment is associated with epigenetic alterations in the promoter of P11 in a genetic model of depression.
    Melas PA; Rogdaki M; Lennartsson A; Björk K; Qi H; Witasp A; Werme M; Wegener G; Mathé AA; Svenningsson P; Lavebratt C
    Int J Neuropsychopharmacol; 2012 Jun; 15(5):669-79. PubMed ID: 21682946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoxetine and S-citalopram inhibit M1 activation and promote M2 activation of microglia in vitro.
    Su F; Yi H; Xu L; Zhang Z
    Neuroscience; 2015 May; 294():60-8. PubMed ID: 25711936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further Evaluation of Mechanisms Associated with the Antidepressantlike Signature of Scopolamine in Mice.
    Martin AE; Schober DA; Nikolayev A; Tolstikov VV; Anderson WH; Higgs RE; Kuo MS; Laksmanan A; Catlow JT; Li X; Felder CC; Witkin JM
    CNS Neurol Disord Drug Targets; 2017; 16(4):492-500. PubMed ID: 28294051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypobaric hypoxia exposure in rats differentially alters antidepressant efficacy of the selective serotonin reuptake inhibitors fluoxetine, paroxetine, escitalopram and sertraline.
    Kanekar S; Sheth CS; Ombach HJ; Olson PR; Bogdanova OV; Petersen M; Renshaw CE; Sung YH; D'Anci KE; Renshaw PF
    Pharmacol Biochem Behav; 2018 Jul; 170():25-35. PubMed ID: 29738811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinically relevant pharmacology of selective serotonin reuptake inhibitors. An overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism.
    Preskorn SH
    Clin Pharmacokinet; 1997; 32 Suppl 1():1-21. PubMed ID: 9068931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinguishing roles for norepinephrine and serotonin in the behavioral effects of antidepressant drugs.
    Lucki I; O'Leary OF
    J Clin Psychiatry; 2004; 65 Suppl 4():11-24. PubMed ID: 15046537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain Histamine Is Crucial for Selective Serotonin Reuptake Inhibitors' Behavioral and Neurochemical Effects.
    Munari L; Provensi G; Passani MB; Galeotti N; Cassano T; Benetti F; Corradetti R; Blandina P
    Int J Neuropsychopharmacol; 2015 Apr; 18(10):pyv045. PubMed ID: 25899065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-dependent influence of buspirone on the activities of selective serotonin reuptake inhibitors in the mouse forced swimming test.
    Redrobe JP; Bourin M
    Psychopharmacology (Berl); 1998 Jul; 138(2):198-206. PubMed ID: 9718290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of noradrenergic tone in the dorsal raphe nucleus of the mouse in the acute behavioral effects of antidepressant drugs.
    O'Leary OF; Bechtholt AJ; Crowley JJ; Valentino RJ; Lucki I
    Eur Neuropsychopharmacol; 2007 Feb; 17(3):215-26. PubMed ID: 16997535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test.
    O'Leary OF; Bechtholt AJ; Crowley JJ; Hill TE; Page ME; Lucki I
    Psychopharmacology (Berl); 2007 Jun; 192(3):357-71. PubMed ID: 17318507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Other Antidepressants.
    Schwasinger-Schmidt TE; Macaluso M
    Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the cortical neurons that mediate antidepressant responses.
    Schmidt EF; Warner-Schmidt JL; Otopalik BG; Pickett SB; Greengard P; Heintz N
    Cell; 2012 May; 149(5):1152-63. PubMed ID: 22632977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidepressant-like activity of selective serotonin reuptake inhibitors combined with a NK1 receptor antagonist in the mouse forced swimming test.
    Chenu F; Guiard BP; Bourin M; Gardier AM
    Behav Brain Res; 2006 Sep; 172(2):256-63. PubMed ID: 16806519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.